Skip to main content
Premium Trial:

Request an Annual Quote

OraSure Completes $50.6M Buy of DNA Genotek

NEW YORK (GenomeWeb News) – OraSure Technologies today announced it has completed its purchase of DNA Genotek for C$50 million (US$50.6 million) in cash.

DNA Genoteck, based in Ottawa, Ontario, will operate as a wholly owned subsidiary of OraSure. The deal, announced in late July, provides OraSure a complementary portfolio of products for the collection, stabilization, transportation, and storage of high quality nucleic acid samples, which can then be used for diagnostic and research purposes.

It also gives Bethlehem, Pa-based OraSure, whose products include antibody-based assays for infectious diseases, a presence in the molecular diagnostics space.

DNA Genoteck has more than 3,000 customers in more than 100 countries, OraSure said. In 2010, DNA Genotek generated approximately $14 million in revenues.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.